SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-04-22 10:40
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
59 - Exercise for cash
$-280,800
-11,232 vol
$25.00 each
0
Filed 2019-04-22 10:39
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
59 - Exercise for cash

-35,970 vol
0
Filed 2019-03-01
Tx date 2019-02-24
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+7,845 vol
11,232
Filed 2019-01-04
Tx date 2018-12-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,142 vol
3,387
Filed 2018-11-29
Tx date 2018-11-06
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+11,990 vol
35,970
Filed 2018-11-29
Tx date 2018-11-06
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
56 - Grant of rights

+11,990 vol
Filed 2018-10-04
Tx date 2018-09-30
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,205 vol
2,245
Filed 2018-07-04
Tx date 2018-06-30
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+807 vol
1,040
Filed 2018-04-17
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+233 vol
233
Filed 2018-04-17
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+233 vol
Filed 2018-04-17
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+233 vol
Filed 2018-04-17
Tx date 2018-01-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-01-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-01-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-16
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+233 vol
233
Filed 2018-04-16
Tx date 2018-01-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-05
Tx date 2018-02-27
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$330,924
+23,980 vol
$13.80 each
Filed 2018-03-05
Tx date 2018-02-27
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$330,924
+23,980 vol
$13.80 each
23,980
Filed 2018-03-02
Tx date 2018-01-31
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-02
Tx date 2018-02-27
$CMTA
Clementia Pharmaceuticals Inc.
Legault, Pierre
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$330,924
+23,980 vol
$13.80 each
23,980